The Advisory Committee on Immunization Practices (ACIP) said the high-dose inactivated (HD-IIV3) and adjuvanted inactivated (allV3) influenza vaccines are acceptable options for vaccinating solid-organ transplant (SOT) recipients ages 18 to 64 years against influenza.
Before this change, this recommendation was only made for SOT patients who were 65 and older.
During the past decade, the number of solid=organ transplants has been increasing steadily with more than 46,632 people receiving a